Cysview Blue Light Cystoscopy Registry

H
Hristos Kaimakliotis, MD

Primary Investigator

Overview

The purpose of this registry is to study the use of BLCC in clinical practice in the United States and to allow researchers access to this data to look at different clinical questions.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Invasive Bladder Cancer
  • Age: Between 18 Years - 100 Years
  • Gender: All

Inclusion Criteria

Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy
Or undergoing surveillance cystoscopy for carcinoma of the bladder

Exclusion Criteria

Polyphyria
Gross Hematuria
Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives

Updated on 09 Mar 2024. Study ID: 1903222683

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center